ENGNW icon

enGene Therapeutics Warrants
ENGNW

17 hedge funds and large institutions have $3.29M invested in enGene Therapeutics Warrants in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 3 reducing their positions, and closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more funds holding in top 10

Funds holding in top 10: →

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
17
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$49K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$45K
2
+$5.41K

Top Sellers

1
-$176K
2
-$9.82K
3
-$3.43K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$2.07M
2
$681K
3
$128K
4
$108K
5
$75.3K
6
$63.4K
7
$42.2K
8
$39.2K
9
$25.6K
10
$22K
11
$13.7K
12
$12K
13
$5.07K
14
$4.76K
15
$213
16
$213
17
$72